ClinicalTrials.gov
ClinicalTrials.gov Menu

DAWBA as a Rapid Online Assessment Tool (eCAP:DAWBA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03120338
Recruitment Status : Active, not recruiting
First Posted : April 19, 2017
Last Update Posted : May 21, 2018
Sponsor:
Collaborator:
NHS Highland
Information provided by (Responsible Party):
University of Aberdeen

Brief Summary:

The European Union is funding this randomised trial in Finland and Scotland as part of the larger eCAP project (http://www.interreg-npa.eu/projects/funded-projects/project/139/). The need for psychiatric services for children and adolescents is usually greater than the services available. As well as this, in many cases, there is confusion as to which service the child or young person should be referred to. The way children and young people arrive at Child and Adolescent Mental Health Services (CAMHS) may therefore be relatively inefficient and families could suffer as a result of this inefficiency.

The use of a computerised structured questionnaire such as the Development and Well-being Assessment (DAWBA) offers the opportunity for these difficulties to be addressed, for the avoidance of 'inappropriate referrals' and for more rational use of resources. It is usually administered online through a secure internet portal. At the end of the data collection, a computerised summary is generated from the data given by all the informants and a child/adolescent psychiatrist lists the likely diagnosis or diagnoses in a summary of the case and gives his view about the next steps. This is then made available to the referrer. This community-based study aims to establish whether using the DAWBA in this way helps children and young people with mental health problems. The main objectives are to improve their mental health, reduce waiting times, change referral practice, increase satisfaction in services and improve cost effectiveness. The principal outcome measure will be parent-rated Strengths and Difficulties Questionnaire (SDQ) score 6 months after randomisation. Secondary outcome measures will include teacher and child-rated SDQ at 6 months and waiting times to services. The investigators will also record service use data and family out -of -pocket costs. A random sample of young people, family and referrers will be interviewed to explore satisfaction with service.


Condition or disease Intervention/treatment Phase
Mental Health Services Diagnostic Test: The Development and Wellbeing Assessment Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 226 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Masking Description: Single Blind
Primary Purpose: Supportive Care
Official Title: eHealth Services for Child and Adolescent Psychiatry (eCAP): A Multi-site Trial of the DAWBA as a Rapid Online Assessment Tool
Actual Study Start Date : April 1, 2017
Estimated Primary Completion Date : June 30, 2019
Estimated Study Completion Date : July 31, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: The Development and Wellbeing Assessment

The Development and Wellbeing Assessment (DAWBA: http://www.dawba.com/) is a computerised structured instrument for gathering diagnostic data from parents or guardians, teachers and young people themselves.

The DAWBA will be administered in addition to care as usual.

Diagnostic Test: The Development and Wellbeing Assessment
The Development and Wellbeing Assessment (DAWBA: http://www.dawba.com/) is a computerised structured instrument for gathering diagnostic data from parents or guardians, teachers and young people themselves.
Other Name: DAWBA

No Intervention: Care as Usual
Care as usual



Primary Outcome Measures :
  1. Parent-rated Strengths and Difficulties Questionnaire [ Time Frame: Six months post randomisation ]
    The Strengths and Difficulties Questionnaire (SDQ) is a brief behavioural screening questionnaire about 3-16 year olds. It exists in several versions to meet the needs of researchers, clinicians and educationalists.


Secondary Outcome Measures :
  1. Child and teacher rated SDQ [ Time Frame: Six months post randomisation ]
    The Strengths and Difficulties Questionnaire (SDQ) is a brief behavioural screening questionnaire about 3-16 year olds. It exists in several versions to meet the needs of researchers, clinicians and educationalists.

  2. Waiting times [ Time Frame: Six months post randomisation ]
    Waiting times to CAMHS first appointment (if any)

  3. Service use costs [ Time Frame: Six month post randomisation ]
    Estimated total service use costs across education, social care, all health (including CAMHS), and voluntary sector.

  4. Onward referral [ Time Frame: Six month post randomisation ]
    Whether or not referral to other agencies (including back to the referrer) took place



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   2 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Participants will be children, young people between the ages of 2 and 17 inclusive and their families at the first point at which contact with CAMHS is being considered by a health professional.

Exclusion Criteria:

  • Lack of fluency in any of the languages available for DAWBA assessment which could be rated by members of the participating CAMHS services would be the only exclusion criterion.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03120338


Locations
United Kingdom
Centre for Rural Health
Inverness, Highland, United Kingdom, IV2 3JH
Sponsors and Collaborators
University of Aberdeen
NHS Highland
Investigators
Principal Investigator: Phil Wilson Centre for Rural Health, University of Aberdeen

Responsible Party: University of Aberdeen
ClinicalTrials.gov Identifier: NCT03120338     History of Changes
Other Study ID Numbers: 17/NS/0002
First Posted: April 19, 2017    Key Record Dates
Last Update Posted: May 21, 2018
Last Verified: May 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University of Aberdeen:
Child and Adolescent
Randomised Controlled Trial
Paediatrics
DAWBA
eHealth Services